GenomeUp vs VitalFields: Revenue, Funding & Team Size Compared
GenomeUp generates $229.9K in revenue; VitalFields generates $235.3K. VitalFields and GenomeUp are close to the same size by revenue. The table below compares GenomeUp and VitalFields on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  GenomeUpThis company |  VitalFields |
|---|---|---|
| Revenue | $229.9K | $235.3K |
| Funding raised | $280.5K | Not disclosed |
| Team size | 31 | 4 |
| Founded | 2017 | 2012 |
| HQ | Rome, Italy | Not disclosed |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
GenomeUp at a glance
GenomeUp generates $229.9K in revenue with 31 employees, headquartered in Rome, Italy.
- Revenue
- $229.9K
- Funding
- $280.5K
- Team size
- 31
- Founded
- 2017
GenomeUp is an AI platform for enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24 hours.
VitalFields at a glance
VitalFields generates $235.3K in revenue with 4 employees.
- Revenue
- $235.3K
- Team size
- 4
- Founded
- 2012
Developer of farm management technologies. The company has designed and developed a moders tool for farm management, field level weather forecasting, plant disease forecasting and farm stock keeping.
Other GenomeUp alternatives
GenomeUp competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
GenomeUp vs VitalFields: frequently asked questions
Is GenomeUp or VitalFields bigger?
VitalFields is the bigger company by revenue, at $235.3K against $229.9K for GenomeUp.
How much revenue does GenomeUp make?
GenomeUp generates $229.9K in annual revenue with a team of 31.
How much revenue does VitalFields make?
VitalFields generates $235.3K in annual revenue with a team of 4.
How much funding has GenomeUp raised?
GenomeUp has raised $280.5K in total funding since it was founded in 2017.